Is it safe to give Bromfed (brompheniramine/pseudoephedrine/dextromethorphan) to a 23‑month‑old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Give Bromfed to a 23-Month-Old Child

Bromfed (brompheniramine/pseudoephedrine/dextromethorphan) should not be given to a 23-month-old child due to lack of efficacy and significant safety concerns, including reported fatalities in this age group. 1

Why This Medication Is Dangerous for Young Children

Lack of Efficacy

  • Controlled trials have demonstrated that antihistamine-decongestant combination products are not effective for treating upper respiratory symptoms in young children 1
  • The efficacy of cough and cold medications has not been established for children younger than 6 years 1

Serious Safety Concerns

Mortality data is particularly alarming:

  • Between 1969-2006, there were 9 fatalities specifically associated with brompheniramine in children under 6 years, with 41 total antihistamine-related deaths reported below age 2 years 1
  • 46 deaths were associated with pseudoephedrine in children ≤6 years, with 43 occurring in infants below age 1 year 1
  • Fatal cases have been documented even with combination products containing these exact ingredients 2, 3

Common mechanisms of fatal overdose include:

  • Use of multiple cold/cough products simultaneously
  • Medication dosing errors by caregivers
  • Accidental exposures by unsupervised children
  • Intentional misuse (sedation or harm) 1, 3

Specific Toxicity Concerns for Each Component

Pseudoephedrine (decongestant):

  • Can cause agitated psychosis, ataxia, hallucinations, and death in infants and young children 1, 4
  • May produce tachyarrhythmias, insomnia, and hyperactivity even at recommended doses 1
  • Blood levels of 14.4 mg/L have been associated with infant fatality 2

Brompheniramine (antihistamine):

  • Blood concentrations as low as 0.40 mg/L have been implicated in infant deaths 2
  • A 2½-year-old survived 300-900 mg, but this demonstrates unpredictable individual responses 5
  • Central nervous system effects range from depression to stimulation, particularly in children 5

Dextromethorphan (cough suppressant):

  • Toxic doses cause drowsiness, ataxia, nystagmus, and convulsive seizures 5
  • Seizures reported in children after ingesting only 13-17 mg/kg 5
  • Blood concentrations of 0.50 mg/L associated with infant fatality 2

FDA and Professional Society Recommendations

The FDA label for Bromfed explicitly states:

  • "Safety and effectiveness in pediatric patients below the age of 6 months have not been established" 5
  • The product is "contraindicated in nursing mothers" due to higher risk of intolerance in small infants 5

Professional guidelines are unequivocal:

  • In October 2007, the FDA's Nonprescription Drugs and Pediatric Advisory Committees recommended that OTC cough and cold medications no longer be used for children below 6 years of age 1
  • Major manufacturers (Wyeth, Novartis, Prestige Brands, Johnson & Johnson) voluntarily removed cough and cold medications for children under age 2 from the market 1

What to Use Instead

For a 23-month-old child with cold symptoms, consider:

Safe Alternatives with Proven Safety Profiles

  • Second-generation antihistamines (cetirizine, loratadine) have been shown to be well tolerated with very good safety profiles in young children 1
  • These are appropriate if allergic rhinitis is the underlying cause

For Acute Cough

  • Honey (for children ≥12 months) may offer relief and is safer than OTC medications 6
  • Supportive care and observation are preferred over pharmacologic intervention 6

For Nasal Congestion

  • Intranasal corticosteroids are the most effective medication class for rhinitis symptoms 1
  • Saline nasal irrigation
  • Humidified air

Critical Pitfalls to Avoid

  1. Never assume "a little bit won't hurt" - Individual responses are unpredictable, and even small amounts have caused serious toxicity 5

  2. Do not use multiple products simultaneously - This was a common factor in fatal overdoses 1

  3. Avoid using these medications for sedation - This accounted for 17.5% of fatalities in one surveillance study 3

  4. Remember that most childhood coughs are self-limited - The natural history of viral upper respiratory infections is resolution without specific treatment 6, 7

Related Questions

What is the recommended dose of Bromfed DM (brompheniramine/pseudoephedrine/dextromethorphan) syrup for adults and children?
What is the appropriate dose of Bromfed (brompheniramine/dextromethorphan/pseudoephedrine) for a child weighing 29.94 kg?
What is the appropriate Bromfed (brompheniramine maleate/pseudoephedrine/dextromethorphan) dose for a child weighing 20.64 kg?
Is it safe to give an 8-year-old with a cough both Bromfed DM (brompheniramine/pseudoephedrine/dextromethorphan) and Benadryl (diphenhydramine), and what are the appropriate doses?
What are the dosing guidelines for Bromfed (brompheniramine + dextromethorphan + pseudoephedrine) in adults, children of various age groups, and infants, and what precautions should be observed?
What are the key components and questions to cover during an initial psychiatric visit for a patient with Alzheimer’s disease and reduced cognitive capacity?
What is the appropriate management for an acute abscess in hidradenitis suppurativa?
Is prescribing dextroamphetamine (extended‑release) 20 mg twice daily appropriate, and what monitoring guidelines should be followed?
What are the indications, starting dose, titration schedule, renal dose adjustments, side effects, tapering recommendations, and alternative therapies for pregabalin?
For a 72-year-old male with type 2 diabetes and obesity who is on tirzepatide (Mounjaro) 5 mg weekly and glipizide extended‑release 5 mg daily, what are the recommended management steps?
What is the recommended intravenous (IV) dose of labetalol?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.